Abbott’s mechanical circulatory support device, HeartMate 3 LVAD, is tailored for individuals with advanced heart failure.

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized ...

but two others from Biotronik and Abbott Medical have not passed muster. The algorithms are designed to detect the early signs of worsening heart failure in people with CIEDs – pacemakers ...

Abbott (NYSE: ABT) today announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options.

Abbott’s HeartMate 3™ LVAD is a mechanical circulatory support device designed for patients with advanced heart failure. Abbott’s heart pumps have set the standard in LVAD therapy.